Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay

Objective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to i...

Full description

Bibliographic Details
Main Authors: Jon P. Williams, Justin R. Abbatemarco, Jonathan J. Galli, Stefanie J. Rodenbeck, Lisa K. Peterson, Thomas R. Haven, Meagan Street, John W. Rose, John E. Greenlee, M. Mateo Paz Soldan, Stacey L. Clardy
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Multiple Sclerosis International
Online Access:http://dx.doi.org/10.1155/2021/8692328
id doaj-d0d7b899e2834237870a4145c0789a6a
record_format Article
spelling doaj-d0d7b899e2834237870a4145c0789a6a2021-10-11T00:39:12ZengHindawi LimitedMultiple Sclerosis International2090-26622021-01-01202110.1155/2021/8692328Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used AssayJon P. Williams0Justin R. Abbatemarco1Jonathan J. Galli2Stefanie J. Rodenbeck3Lisa K. Peterson4Thomas R. Haven5Meagan Street6John W. Rose7John E. Greenlee8M. Mateo Paz Soldan9Stacey L. Clardy10Department of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyARUP Institute for Clinical and Experimental PathologyARUP Institute for Clinical and Experimental PathologyARUP Institute for Clinical and Experimental PathologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyObjective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to identify all patients at the University of Utah who had AQP4 ELISA testing at ARUP Laboratories from 2010 to 2017. We then reviewed their diagnostic evaluation and final diagnosis based on the ELISA titer result. Results. A total of 750 tests for the AQP4 ELISA were analyzed, and 47 unique patients with positive titers were identified. Less than half of these patients (49%) met the clinical criteria for neuromyelitis optica spectrum disorder (NMOSD). In cases of low positive titers (3.0–7.9 U/mL, n=19), the most common final diagnosis was multiple sclerosis (52.6%). In the moderate positive cohort (8.0–79.9 U/mL, n=14), only a little more than half the cohort (64.3%) had NMOSD. In cases with high positives (80–160 U/mL, n=14), 100% of patients met clinical criteria for NMOSD. Conclusions. Our data illustrates diagnostic uncertainty associated with the AQP4 ELISA, an assay that is still commonly ordered by clinicians despite the availability of more sensitive and specific tests to detect AQP4 autoantibodies in patients suspected of having NMOSD. In particular, low positive titer AQP4 ELISA results are particularly nonspecific for the diagnosis of NMOSD. The importance of accessibility to both sensitive and specific AQP4 testing cannot be overemphasized in clinical practice.http://dx.doi.org/10.1155/2021/8692328
collection DOAJ
language English
format Article
sources DOAJ
author Jon P. Williams
Justin R. Abbatemarco
Jonathan J. Galli
Stefanie J. Rodenbeck
Lisa K. Peterson
Thomas R. Haven
Meagan Street
John W. Rose
John E. Greenlee
M. Mateo Paz Soldan
Stacey L. Clardy
spellingShingle Jon P. Williams
Justin R. Abbatemarco
Jonathan J. Galli
Stefanie J. Rodenbeck
Lisa K. Peterson
Thomas R. Haven
Meagan Street
John W. Rose
John E. Greenlee
M. Mateo Paz Soldan
Stacey L. Clardy
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
Multiple Sclerosis International
author_facet Jon P. Williams
Justin R. Abbatemarco
Jonathan J. Galli
Stefanie J. Rodenbeck
Lisa K. Peterson
Thomas R. Haven
Meagan Street
John W. Rose
John E. Greenlee
M. Mateo Paz Soldan
Stacey L. Clardy
author_sort Jon P. Williams
title Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
title_short Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
title_full Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
title_fullStr Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
title_full_unstemmed Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
title_sort aquaporin-4 autoantibody detection by elisa: a retrospective characterization of a commonly used assay
publisher Hindawi Limited
series Multiple Sclerosis International
issn 2090-2662
publishDate 2021-01-01
description Objective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to identify all patients at the University of Utah who had AQP4 ELISA testing at ARUP Laboratories from 2010 to 2017. We then reviewed their diagnostic evaluation and final diagnosis based on the ELISA titer result. Results. A total of 750 tests for the AQP4 ELISA were analyzed, and 47 unique patients with positive titers were identified. Less than half of these patients (49%) met the clinical criteria for neuromyelitis optica spectrum disorder (NMOSD). In cases of low positive titers (3.0–7.9 U/mL, n=19), the most common final diagnosis was multiple sclerosis (52.6%). In the moderate positive cohort (8.0–79.9 U/mL, n=14), only a little more than half the cohort (64.3%) had NMOSD. In cases with high positives (80–160 U/mL, n=14), 100% of patients met clinical criteria for NMOSD. Conclusions. Our data illustrates diagnostic uncertainty associated with the AQP4 ELISA, an assay that is still commonly ordered by clinicians despite the availability of more sensitive and specific tests to detect AQP4 autoantibodies in patients suspected of having NMOSD. In particular, low positive titer AQP4 ELISA results are particularly nonspecific for the diagnosis of NMOSD. The importance of accessibility to both sensitive and specific AQP4 testing cannot be overemphasized in clinical practice.
url http://dx.doi.org/10.1155/2021/8692328
work_keys_str_mv AT jonpwilliams aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT justinrabbatemarco aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT jonathanjgalli aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT stefaniejrodenbeck aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT lisakpeterson aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT thomasrhaven aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT meaganstreet aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT johnwrose aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT johnegreenlee aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT mmateopazsoldan aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
AT staceylclardy aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay
_version_ 1716829229382893568